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proliferative activity and metastatic behavior.c 2005 Elsevier Ltd. All rights reserved.
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7Introduction
Epithelioid hemangioendothelioma (EH) is a rare vascular
tumour, which was described first by Weiss and Enzinger.1
This tumour shows an intermediate malignant potential be-
tween hemangioma and angiosarcoma.2 EH rarely occurs in
the oral cavity, to our knowledge, only 15 cases have been
reported.3–15 In those cases, only two cases of EH in the
tongue have been reported.4,13 The behavioral nature of741-9409/$ - see front matter c 2005 Elsevier Ltd. All rights reserved
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E-mail address: uehara@net.nagasaki-u.ac.jp (M. Uehara).EH in the tongue is unknown because of the rarity. We de-
scribe here the EH manifested in the tongue together with
its immunohistochemical findings.Case report
A 72-year-old Japanese man presented with 2 months
history of a slowly growing painless swelling in the tongue
dorsum. The patient’s medical history was noncontributory.
The extraoral examination was negative for swelling, ten-
derness, or lymphadenopathy. A hemispheric swelling
(7 · 7 mm) involved in the left side of the tongue dorsum.
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the diagnosis, biopsy was perform under a local anesthesia.
Histologically, the haematoxylin–eosin (H–E) stained spec-
imen showed a submucosal nodule composed of plump cells
with large nuclei and distinct cell border. Scattered vascular
channels containing erythrocytes were seen in the dodule,
where mitotic figures were sparsely found (Fig. 2). These
findings made diagnosis of epithelioid hemangioendotheli-
oma (EH). The lesion was excised with the safety margin
of 10 mm. No tumour involvement was microscopically
shown in the surgical margin.
Reticulin staining as well as immunohistochemical stain-
ing for factor VIII (1:200 diluted, DAKO N1505) were per-
formed to confirm the diagnosis. The reticulin staining
highlighted fibrous materials surrounding the individual tu-
mour cells (Fig. 3). This staining demonstrated a dense
reticulin network that surrounds individual tumour cells,
and this finding is one of the features of tumour originated
from endothelial cell.16 The positive reaction to anti-factorFigure 1 Mass of the tongue dorsum without ulceration.
Figure 2 Submucosal nodule composed of plump cells with
large nuclei (haematoxylin and eosin staining ·200).VIII was demonstrated in the cytoplasm of the tumour cells.
This vascular marker was more accentuated at the sites
where vascular lumina were formed (Fig. 4).
Furthermore, the proliferative activity of this tumour
was evaluated by immunohistochemical staining of prolifer-
ating cell nuclear antigen (PCNA; 1:100 diluted, Santa Cruz
FL-261) (Fig. 5). Both labeled and unlabeled tumour cells in
the square field (0.25 mm · 0.25 mm) were counted at a
magnification of 400·. The PCNA labeling index (LI) was
calculated as the percentage of the PCNA-positive cells in
1000 tumour cells counted from randomly selected four
fields. The PCNA LI amounted to 57.0%. Immunohistochem-
ical expression of vascular endothelial growth factor (VEGF;
1:200 diluted, Santa Cruz A-20) in the tumour was also
investigated to reveal its behavioral nature. VEGF was
stained strongly in the cytoplasm (Fig. 6).Figure 3 Reticular fiber around the cells (reticulin staining
·400).
Figure 4 The strongly positive factor VIII in the cytoplasm of
the tumour cells (immunohistochemical staining ·400).
Figure 6 VEGF expression predominantly located in the
cytoplasm of the tumour cells (immunohistochemical staining
·400).
Figure 5 PCNA positive for nuclei (immunohistochemical
staining ·400).
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Weiss et al.2 reported the prognosis of 46 cases of EH, which
were followed up for 48 months on average. They described
that local recurrence included 6 cases (13%), and metastasis
to regional lymph nodes and/or other organs 14 cases (31%).
Therefore, radical excision of the lesion with adequate
margin was obtained, taking into account the risk of local
recurrence in this case.
The present case expressing the high LI of PCNA is sug-
gestive of its clinical outcome as well as aggressive prolifer-
ation. In addition, angiogenesis plays an important role in
tumour growth and metastasis.17 VEGF is a dimeric polypep-
tide growth factor, and its mitogenic activity is specific for
vascular endothelial cells.18,19 The intense expression of
VEGF in EH may indicate its aggressive proliferative activity
and metastatic behavior as well.Because of its remarkable cellularity and the mitotic
activity, EH can be confused with carcinoma.1 The immuno-
histological staining for factor VIII helps to differentiate EH
from carcinoma.20 Critical therapy and follow-up must be
required because of its semi-malignant potential.
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